‹ News Blitz Social Settled

Imported medicines must generally have at least one year before expiry

English हिंदी ಕನ್ನಡ മലയാളം தமிழ் తెలుగు

First brief 1 Nov, 8:53 pm IST Updated 1 Nov, 8:53 pm IST 0 developments 3 min read

Remaining shelf life of medicines. — Clarity · AI illustration

Where it stands

India has changed how much usable life most imported medicines must have when they enter the country. The October 2026 amendment sets a minimum of one year remaining before expiry. Previously, the rule generally required more than 60% of the medicine’s approved shelf life to remain. The difference is easiest to see with a hypothetical medicine whose total shelf life is three years. Under the earlier rule, more than 21.6 months had to remain at import. Under the new rule, a batch with 15 months remaining can meet this particular condition. It must still satisfy all other applicable requirements. The change gives importers more flexibility for medicines with longer shelf lives. It does not extend a medicine’s expiry date or permit the sale of expired stock. Nor does a fixed twelve-month threshold necessarily relax the rule for every product; the effect depends on its total shelf life. There is an important exception. Biological drugs and radiopharmaceuticals retain a percentage-based provision allowing 60% of their labelled shelf life. The new one-year rule therefore cannot be applied indiscriminately to every imported medicine.

Background

A medicine’s shelf life is the period during which it is expected to meet its approved standards under specified storage conditions. The expiry date marks the end of that period. By the time a batch reaches India, manufacturing, storage and transport may already have used up part of its shelf life. The time still available is its residual shelf life. Import rules set a minimum because medicines need time to pass through distribution before they reach patients. A batch with too little time remaining can expire before it is used, creating wastage and supply problems. A percentage rule links the required remaining time to the product’s total approved life. A fixed-time rule instead uses the same number of remaining months for most products. The two approaches can produce different results, which is why the total shelf life matters when assessing the change. For example, a longer-lived product can arrive later in its life while still leaving a full year for distribution and use. That may make stock planning easier. But the import condition alone does not establish that a particular batch is suitable in every other respect. Quality, storage and other regulatory requirements still apply. The amendment changes this entry condition in the Drugs Rules. It does not grant patients a new entitlement or guarantee lower medicine prices. Any benefit from easier supply will depend on how importers and the distribution system respond.

How it developed

October 2026: Rule 31 amended

How it started
A fixed one-year import condition replaces the general percentage rule

The Health Ministry has amended Rule 31 through the Drugs (Thirteenth Amendment) Rules, 2026. The new text prevents import where less than one year of residual shelf life remains, subject to the stated specialised-product provision. Biological drugs and radiopharmaceuticals are treated separately: 60% of their labelled shelf life may be allowed. The amendment changes the amount of time required at import. It does not reset the date printed on the medicine or remove other regulatory checks.

Gazette of India / Health Ministry Business Standard

Why it matters for UPSC

GS2 · Public healthGS2 · Regulation

Compare percentage-based regulation with a fixed-time threshold using the same example before and after the change. Connect medicine supply, wastage and public-health safeguards. Distinguish remaining shelf life at import from the expiry date itself.

Key terms

Shelf lifeThe approved period during which a medicine is expected to remain within its required standards under specified storage conditions. It is not a promise that poor storage has no effect. The total shelf life and the time still remaining at import are different quantities.

Residual shelf lifeThe part of a medicine’s shelf life that remains at a particular point. Here, the relevant point is its entry into India. A medicine with three years of total shelf life may have much less time left after manufacturing, storage and transport.

Expiry dateThe date marking the end of the medicine’s approved usable period under the stated conditions. Changing the import rule does not move this date forward. A batch that qualifies for import must still be handled and used within the applicable requirements.

Biological drugsMedicines made from, or using, biological sources and processes. They include products such as vaccines. The amendment treats this category separately through a percentage-based shelf-life provision. The general one-year condition should not be assumed to apply in the same way.

RadiopharmaceuticalsMedicinal products containing radioactive substances, used for purposes such as diagnosis or treatment. Their characteristics require specialised controls. The amendment expressly includes them in the separate provision allowing 60% of labelled shelf life.

Import conditionA requirement that must be met when goods enter a country. Meeting one condition does not remove the others. A medicine that passes the residual shelf-life test must still meet applicable licensing, quality and other requirements.

Sources (2)

Gazette of India / Health Ministry · official · GSR 951(E): Drugs (Thirteenth Amendment) Rules, 20261 Nov, 2:20 pm
Business Standard · Minimum residual shelf life for imported drugs1 Nov, 2:20 pm